Белумосудил (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Белумосудил" in Russian language version.

refsWebsite

Global rank Russian rank

4^th place

6^th place

2^nd place

3^rd place

doi.org

Blair, H. A. (2021). Belumosudil: first approval. Drugs, 81(14), 1677-1682. PMID 34463931 PMC 8590654 doi:10.1007/s40265-021-01593-z
Ali, F., & Ilyas, A. (2022). Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease. Current research in translational medicine, 70(3), 103343. PMID 35339032 doi:10.1016/j.retram.2022.103343
Beckers, C. M., Knezevic, N., Valent, E. T., Tauseef, M., Krishnan, R., Rajendran, K., ... & van Nieuw Amerongen, G. P. (2015). ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension. Vascular pharmacology, 70, 45-54. PMID 25869521 PMC 4606924 doi:10.1016/j.vph.2015.03.017
Newell-Litwa, K. A., Badoual, M., Asmussen, H., Patel, H., Whitmore, L., & Horwitz, A. R. (2015). ROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity. Journal of Cell Biology, 210(2), 225-242. PMID 26169356 PMC 4508895 doi:10.1083/jcb.201504046
Zanin-Zhorov, A., & Blazar, B. R. (2021). ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease. Clinical Immunology, 230, 108823. PMID 34400321 PMC 8456981 doi:10.1016/j.clim.2021.108823

Blair, H. A. (2021). Belumosudil: first approval. Drugs, 81(14), 1677-1682. PMID 34463931 PMC 8590654 doi:10.1007/s40265-021-01593-z
Ali, F., & Ilyas, A. (2022). Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease. Current research in translational medicine, 70(3), 103343. PMID 35339032 doi:10.1016/j.retram.2022.103343
Beckers, C. M., Knezevic, N., Valent, E. T., Tauseef, M., Krishnan, R., Rajendran, K., ... & van Nieuw Amerongen, G. P. (2015). ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension. Vascular pharmacology, 70, 45-54. PMID 25869521 PMC 4606924 doi:10.1016/j.vph.2015.03.017
Newell-Litwa, K. A., Badoual, M., Asmussen, H., Patel, H., Whitmore, L., & Horwitz, A. R. (2015). ROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity. Journal of Cell Biology, 210(2), 225-242. PMID 26169356 PMC 4508895 doi:10.1083/jcb.201504046
Zanin-Zhorov, A., & Blazar, B. R. (2021). ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease. Clinical Immunology, 230, 108823. PMID 34400321 PMC 8456981 doi:10.1016/j.clim.2021.108823